Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Sarcoma of the Extremity”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Testing effectiveness (Phase 2)Ended earlyNCT00089544
What this trial is testing

Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft Tissue Sarcoma of the Arm, Leg, or Body Wall

Who this might be right for
Recurrent Adult Soft Tissue SarcomaStage I Adult Soft Tissue Sarcoma AJCC v7Stage II Adult Soft Tissue Sarcoma AJCC v7+1 more
National Cancer Institute (NCI) 23
Testing effectiveness (Phase 2)Study completedNCT00002791
What this trial is testing

Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue Sarcoma

Who this might be right for
Sarcoma
Radiation Therapy Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00023738
What this trial is testing

Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma

Who this might be right for
Sarcoma
Radiation Therapy Oncology Group
Large-scale testing (Phase 3)UnknownNCT02120768
What this trial is testing

Role of Barrier Resection in Local Control for Extremity Recurrent Soft Tissue Sarcomas

Who this might be right for
Local Recurrence of Malignant Tumor of Soft Tissue
Fudan University 400
Early research (Phase 1)Ended earlyNCT03727789
What this trial is testing

CBL0137 in Treating Patients With Advanced Extremity Melanoma or Sarcoma

Who this might be right for
Advanced Cutaneous Melanoma of the ExtremityAdvanced Sarcoma of the ExtremityClinical Stage III Cutaneous Melanoma AJCC v8+10 more
Roswell Park Cancer Institute 7
Testing effectiveness (Phase 2)Study completedNCT00019968
What this trial is testing

Isolated Limb Perfusion of Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Soft Tissue Sarcoma of the Arm or Leg

Who this might be right for
Stage IVB Adult Soft Tissue SarcomaStage IIB Adult Soft Tissue SarcomaStage IIC Adult Soft Tissue Sarcoma+3 more
National Institutes of Health Clinical Center (CC)
Not applicableUnknownNCT00900211
What this trial is testing

Tissue Sample Collection From Patients With Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet Treated on Clinial Trial CRUK-VORTEX

Who this might be right for
Sarcoma
The Christie NHS Foundation Trust 400
Testing effectiveness (Phase 2)Study completedNCT00004250
What this trial is testing

Isolated Limb Infusion of Chemotherapy in Treating Patients With Melanoma or Soft Tissue Sarcoma of the Arm or Leg That Cannot Be Removed By Surgery

Who this might be right for
Melanoma (Skin)Sarcoma
Memorial Sloan Kettering Cancer Center 35
Not applicableWithdrawnNCT02507076
What this trial is testing

Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or Sarcoma

Who this might be right for
Basal Cell Carcinoma of the SkinEccrine Carcinoma of the SkinRecurrent Adult Soft Tissue Sarcoma+8 more
Albert Einstein College of Medicine
Testing effectiveness (Phase 2)Study completedNCT00330421
What this trial is testing

Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07)

Who this might be right for
Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorMetastatic OsteosarcomaRecurrent Adult Soft Tissue Sarcoma+6 more
National Cancer Institute (NCI) 15